A study found that adults with ADHD on average miss more than three weeks per year in workplace productivity. Sacramento Bee Lunch rush was over, but distractions remained numerous inside the cafe just off a highway in Auburn, Calif. Blenders whirred out smoothies every few minutes, laughter erupted from a nearby group, ... Read More

Lunch rush was over, but distractions remained numerous inside the La Bou cafe just off Highway 49 in Auburn. Blenders whirred out smoothies every few minutes, laughter erupted from a nearby group, a young worker noisily cleared tables. Yet, through it all, Cass Brown Capel stayed focused -- eyes locked on ... Read More

Lenard A. Adler, M.D.; David W. Goodman, M.D.; Scott H. Kollins, Ph.D.; Richard H. Weisler, M.D.; Suma Krishnan, M.S.; Yuxin Zhang, Ph.D.; and Joseph Biederman, M.D., on behalf of the 303 Study Group. Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. Published ... Read More

For adults withADHD, the standard treatment is medication. But experts say that ADHD therapy -- and other psychosocial treatments -- can play a key role alongside drugs. “I think for many adults with ADHD, therapy is essential,” says David W. Goodman MD, assistant professor of psychiatry at the Johns Hopkins University School of Medicine. Recommended Related to ... Read More

Your son or daughter was just diagnosed with ADHD, or attention deficit hyperactivity disorder. And as you sat there in the office, listening to the doctor tick off the symptoms – the attention problems, the disorganization, the fidgeting – you recognized yourself. Suddenly, you wonder: Could I have adult ADHD? You ... Read More

ATLANTA, July 22 /PRNewswire-FirstCall/ — Shire Limited , the global specialty biopharmaceutical company, today announced that it has launched VYVANSE(TM) (lisdexamfetamine dimesylate) for the treatment of adults with Attention Deficit Hyperactivity Disorder (ADHD). This launch follows the recent FDA approval of VYVANSE to treat ADHD in the adult population. VYVANSE ... Read More

MONDAY, July 7 (HealthDay News) -- Children with attention-deficit hyperactivity disorder (ADHD) are at a 50 percent higher risk for being overweight if they are not taking medication for the condition, a new study finds. On the other hand, youngsters who were medicated for ADHD had a raised risk of being ... Read More

TUESDAY, May 27 (HealthDay News) -- Adults with attention deficit hyperactivity disorder (ADHD) miss, on average, more than three weeks a year in workplace productivity, according to a new global reckoning of the problem. Altogether, between 3 percent and 4 percent of adults worldwide have ADHD, according to survey data from ... Read More